The United States Food and Drug Administration has granted approval for Waskyra, marking a significant milestone as the first gene therapy authorised for the treatment of Wiskott-Aldrich syndrome. The therapy,
The United States Food and Drug Administration has granted approval for Waskyra, marking a significant milestone as the first gene therapy authorised for the treatment of Wiskott-Aldrich syndrome. The therapy,
Aspirin has held a central role in cardiovascular prevention for over a century with millions depending on a daily low dose to ward off heart attacks and strokes. Yet new
Scientists at the Massachusetts Institute of Technology have harnessed artificial intelligence to design two innovative antibiotics capable of combating superbugs such as MRSA. This breakthrough could usher in a new
President Donald Trump has issued an executive order aimed at tackling high drug prices in the United States, sparking concern and volatility across the global pharmaceutical industry. The announcement marks
AstraZeneca, the FTSE 100 pharmaceutical giant, has reaffirmed its full-year forecasts despite posting mixed first-quarter results and grappling with potential headwinds in major markets. The company reported a 10 per
The Swiss pharmaceutical giant Roche has announced a partnership with Danish biotechnology firm Zealand Pharma in a deal valued at up to $5.3 billion. The collaboration aims to develop and
Swiss pharmaceutical giant Roche has finalised a £4.4 billion deal with Danish biotech firm Zealand Pharma to develop and commercialise a next-generation obesity treatment. The agreement focuses on Petrelintide, a
The recent alignment of seven major planets over Britain coincided with promising developments in the field of genetics, particularly for UK-based Genomics, a genetic analytics firm spearheading a transformative approach
In a groundbreaking announcement at the World Economic Forum in Davos, Sir Demis Hassabis revealed that Isomorphic Labs, the Alphabet-owned drug discovery startup, will commence trials of its first AI-designed
In a significant strategic pivot, artificial intelligence drug discovery company BenevolentAI is contemplating a return to the London markets by 2026, following its planned delisting from Euronext Amsterdam. The company’s
Artificial intelligence is revolutionising pharmaceutical research, offering groundbreaking opportunities for drug discovery whilst potentially saving billions in development costs. Leading pharmaceutical giants GSK and AstraZeneca are at the forefront of
The pharmaceutical industry has witnessed a dramatic decline in deal activity, reaching its lowest point in nearly a decade as major drugmakers pivot away from commercially ready medicines towards early-stage
The largest pharmaceutical company in Britain has signed a license agreement with a Chinese firm that could be worth up to $ 2 billion. This is to develop a drug
Roche has raised hopes that the Swiss pharmaceutical company may have a blockbuster drug in its hands. Early trial results showed rapid weight loss for recipients of new treatments from
Linda Medendorp learned that she would die the day her son turned 18. Tests revealed that after a 51-year old woman complained of persistent swallowing problems, she had an incurable
In a significant development in the fight against lung cancer, doctors have initiated the world’s first mRNA lung cancer vaccine trials in patients across seven countries. This pioneering jab, known






